Article Text

PDF
Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3
  1. W-M Chan1,
  2. E I Traboulsi2,
  3. B Arthur3,
  4. N Friedman4,
  5. C Andrews1,
  6. E C Engle1
  1. 1Program in Genomics, Children’s Hospital Boston, Boston, MA, USA
  2. 2Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
  3. 3Department of Ophthalmology, Queen’s University, Kingston, Ontario, Canada
  4. 4Department of Pediatric Neurology, Cleveland Clinic Foundation, Cleveland, OH, USA
  1. Correspondence to:
 Dr Elizabeth C Engle
 Enders 560.2, Children’s Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA; elizabeth.engle{at}childrens.harvard.edu

Abstract

Background: Horizontal gaze palsy with progressive scoliosis (HGPPS) is an autosomal recessive disorder characterised by congenital absence of horizontal gaze, progressive scoliosis, and failure of the corticospinal and somatosensory axon tracts to decussate in the medulla. We previously reported that HGPPS patients from consanguineous pedigrees harbour homozygous mutations in the axon guidance molecule ROBO3.

Methods: We now report two sporadic HGPPS children of non-consanguineous parents who harbour compound heterozygous mutations in ROBO3. The mother of one of the children also had scoliosis DNA was extracted from a blood sample from each participant using a standard protocol, and the coding exons of ROBO3 were amplified and sequenced as previously described.

Results: Each patient harboured two unique heterozygous mutations in ROBO3, having inherited one mutation from each parent.

Conclusions: HGPPS can result from compound heterozygous mutations. More comprehensive examinations of parents and siblings of HGPPS patients are required to determine if the incidence of scoliosis in individuals harbouring heterozygous ROBO3 mutations is greater than in the general population.

  • HGPPS
  • horizontal gaze palsy
  • scoliosis
  • ROBO3

Statistics from Altmetric.com

Footnotes

  • This work was supported by NIH-R01-EY015298 and NIH-R01-EY13583 to ECE, and NIH P30HD-18655 (Children’s Hospital Mental Retardation and Developmental Disabilities Center)

  • Competing interests: none declared

  • Consent was received for the publication of these patient details

    Ethics approval: all necessary ethics committee approval was secured for the study reported, as stated in the article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.